Abstract:Background SAPHO syndrome is a rare disease with the typical involvement of the anterior chest wall. The spinal involvement is more often than we thought and less understood by us. Objectives To assess the clinical and imaging features of the spinal involvement in SAPHO syndrome. Methods Patients diagnosed with SAPHO syndrome in Peking University Third Hospital from 2006 to 2018 were recruited. Patients were divided into spinal involvement group and non-spinal involvement group. Patients with AS (ankylosing spondylitis) were recruited as control group. Their clinical data, laboratory data and imaging data (CT, MRI and radionuclide imaging) were collected and were conpared. All the patients with SAPHO syndrome were followed up regularly. Results Totally 46 SAPHO patients were included (17 male and 29 female) and 34 patients (73.9%) had spinal involvement. The mean age was 50.2±10.9 years and the mean disease duration was 5.4±6.4 years. 50 patients with AS were also included. Compared with non-spinal involvement group, the age at disease onset in spinal involvement group was older, the disease duration was longer,t;he CRP elevation was more often and the anterior chest wall involvement was less often (table 1). In spinal involvement group, the thoracic spine was most commonly involved and the vertebral inflammatory changes including bone marrow edema were often seen. These patients were more likely to suffer from cervical spine involvement, endplate inflammation and spondyldiscitis (table 2).Abstract AB1081 Table 1 characteristics of SAPHO syndrome patients with and without spinal involvement characteristics Spinal involvement (n=34) Non-spinal involvement (n=12) P value Sex, female 21(61.8%) 8(36.7%) NS Age at diagnosis, yrs 52.2±10.3 44.6±10.6 0.033* Disease duration, yrs 6.1±7.1 3.1±2.4 0.048* Dermatological disorders 19(55.9%) 10(83.3%) NS CRP elevated 21 (4.6±12.1) 4 (3.0±4.3) 0.047* ESR elevated 16 (31.2±24.0) 6 (32.2±27.2) NS TNF-αelevated 12 (58.6±55.9) 13 (45.3±22.7) NS IL-6 elevated 18 (320.5±343.9) 42 (48.6±328.2) NS sternoclavicular 18 12 0.003* Clavicle 6 2 NS First rib 8 5 NS Sternocostal joint 6 2 NS Sternum corner 1 3 0.02* Manubrium 6 0 NS Sacroiliac joint 6 5 NSAbstract AB1081 Table 2 characteristics of SAPHO syndrome and AS patients with spinal involvement characteristics SAPHO (n=34) AS (n=50) P value Sex, female 21(61.8%) 17(34.0%) 0.012* Age at onset, yrs 52.2±10.3 35.4±12.0 0.0008* Disease duration, yrs 6.1±7.1 7.4±7.3 NS CRP elevated 16(4.6±12.1) 26 (2.11±2.52) NS ESR elevated 16 (31.2±24.0) 18 (28.4±24.6) NS HLA-B27 positive 1(2.9%) 48(96.0%) 0.000* Cervical vertebra 17(50.0%) 13(26.0%) 0.024* Thoracic vertebra 22(64.7%) 33(66.0%) NS Lumbar vertebra 17(50%) 34(68.0%) NS Contiguous/multiple vertebra involvement 28(82.4%) 50(100%) 0.002* Vertebral inflammation 34(100%) 48(96.0%) NS Endplate inflammation 8(23.5%) 3(6.0%) 0.019* Spondylodiscitis 16(47.1%) 4(8.0%) 0.001* Vertebral body corner involvement 11(32.4%) 13(26.0%) NS Paravertebral ossification 4(11.8%) 5(10.0%) NS All the SAPHO patients with spinal involvement were followed up. 30 patients received NSAIDs plus DMARDS/biologics and the symptoms improved. Reexamined imaging data of 10 patients were available and the spinal involvement became better. Conclusion 73.9% of SAPHO patients had spinal involvement and they were more likely to suffer from cervical spine involvement, endplate inflammation and spondyldiscitis. The combination of NSAIDS and biologics/DMARDs were helpful to improve the symptoms. References [1] Mcgauvran A M, Kotsenas A L, Diehn F E, et al. SAPHO Syndrome: Imaging Findings of Vertebral Involvement.[J]. Ajnr Am J Neuroradiol, 2016, 37(8). Acknowledgement This study was supported by a Project of the National Natural Science Foundation of China (81501390). Disclosure of Interests None declared

Association Between Disease Activity and Osteocalcin, Β-Isomerized C-terminal Telopeptides in SAPHO Syndrome

Vitamin D in Ankylosing Spondylitis: Review and Meta-Analysis

Relapse of Low Back Pain after Internal Lumbar Fixation Was Diagnosed with SAPHO Syndrome: A Case Report.

Correlative study on the relationship between serum OPG and sRANK and coronary artery lesions in patients with coronary heart disease

SERUM C-C MOTIF LIGAND 11/EOTAXIN-1 MAY SERVE AS A CANDIDATE BIOMARKER FOR POSTMENOPAUSAL OSTEOPOROSIS

Serum-derived extracellular vesicles inhibit osteoclastogenesis in active-phase patients with SAPHO syndrome

Relationship Between Disease Activity and Th17/regulatory T Cells Level in Peripheral Blood of Patients with Synovitis Acne Pustulosis Hyperostosis Osteitis Syndrome

Bone Loss in Patients with SAPHO Syndrome: a Preliminary Study

Cluster analysis of clinical phenotypes and its implication in 164 patients with Synovitis-Acne-Pustulosis-Hyperostosis-Osteitis syndrome

The Clinical Characteristics and Prognosis of Patients with SAPHO Syndrome--a Real-World Cohort Study.

[Clinical Observation of Chaihu Guizhi Decoction in Treating SAPHO Syndrome]

99Tcm-MDP whole body bone imaging in 25 patients with SAPHO syndrome

The Comparison Analysis of Clinical and Radiological Features in SAPHO Syndrome

AB1081 A COMPARATIVE STUDY ON THE FEATURES OF THE SPINAL INVOLVEMENT IN SAPHO SYNDROME

Increased Serum Levels and Chondrocyte Expression of Nesfatin-1 in Patients with Osteoarthritis and Its Relation with BMI, Hscrp, and IL-18

Serum Oxytocin Levels in Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis and their Association with Disease Activity

The effectiveness of treatments for patients with SAPHO syndrome: a follow-up study of 24 cases from a single center and review of literature

Ultrasound Assessment of Entheses and Correlations Between Disease Activity and Ultrasound Scores in Ankylosing Spondylitis: A Cross Sectional Study

Comparative analysis and differentiation between SAPHO syndrome and spondyloarthropathies using whole-spine MRI

Association between systemic inflammatory response index and bone turnover markers in Chinese patients with osteoporotic fractures: a retrospective cross-sectional study

Serum levels of interleukin-34 and RANKL as multivariable predictors of bone erosion seen by ultrasonography in patients with ankylosing spondylitis